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Spinocerebellar ataxia type 1 (SCA1) is an autosomal-dominant neurodegenerative disorder characterized by ataxia and progressive motor
deterioration. SCA1 is associated with an elongated polyglutamine tract in ataxin-1, the SCA1 gene product. Using the yeast two-hybrid
system and co-immunoprecipitation experiments, we have found that p80 coilin, coiled body-specific protein, binds to ataxin-1. In further
experiments with deletion mutants, we found that the C-terminal regions of ataxin-1 and p80 coilin were essential for this interaction. In
HeLa cells that have been co-transfected with ataxin-1 and p80 coilin, the p80 coilin protein co-localizes with ataxin-1 aggregates in the
nucleoplasm. However, immunohistochemical analysis and immunofluorescence assays showed that mutant ataxin-1 aggregates do not
redistribute p80 coilin’s dot-like structures in the Purkinje cells of SCA1 transgenic mice. This feature of the interaction between ataxin-1 and
p80 coilin suggests that p80 coilin might be implicated in altering the function of ataxin-1.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Polyglutamine; SCA1; p80 coilin; Coiled body; Yeast two-hybrid
1. Introduction glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [10].Autosomal dominant neurodegenerative disorders asso-
ciated with expansion of the CAG trinucleotide repeats,
which encode polyglutamine, are the most common forms
of familial spinocerebellar degeneration [1]. Disorders char-
acterized by a similar molecular pathology include spino-
cerebellar ataxia type 1 (SCA1) [2], SCA2, -3, -6, -7,
Huntington’s disease (HD), dentatorubralpallidoluysian
atrophy (DRPLA) [3,4], and spinal and bulbar muscular
atrophy (SBMA) [5]. The ataxin-1 protein, the SCA1 gene
product, is found predominantly in the nucleus of neurons
and cytoplasm of peripheral tissues [6].
Selective degeneration of cerebellar Purkinje cells and
brainstem neurons occurs in SCA1 [7], despite the broad
expression patterns of ataxin-1 in the central nervous system
as well as in nonneuronal tissues. Thus, cell-specific pro-
teins might mediate the pathogenesis of SCA1 and other
polyglutamine neurodegenerative disorders. Proteins found
to associate with ataxin-1 include the ubiquitin-specific
protease (USP7) [8], the leucine-rich acidic nuclear protein
(LANP) [9] and the widely expressed glycolytic enzyme,0925-4439/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
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E-mail address: skang@korea.ac.kr (S. Kang).In particular, the interaction between USP7 and ataxin-1 is
significantly weaker when the number of glutamines in
ataxin-1 is increased. However, the contribution of ataxin-
1 to the cellular and molecular mechanisms involved in the
pathogenesis of SCA1 has yet to be elucidated.
To explore the function of ataxin-1, we performed a yeast
two-hybrid screen and identified an ataxin-1-interacting
protein that has complete amino acid identity with the
nuclear specific-coiled body protein, p80 coilin [11]. Both
the wild-type and mutant ataxin-1 proteins interacted with
p80 coilin in the nucleoplasm, but not in the coiled bodies or
other nuclear organelles by our in vivo co-immunoprecipi-
tation experiments, liquid h-galactosidase assays and immu-
nofluorescence assays. The association of p80 coilin and
ataxin-1 might provide insight to the functional mechanism
of ataxin-1.2. Materials and methods
2.1. DNA constructs
The cloning and characterization of the ataxin-1 were
described previously [8]. The plasmid pcDNA/amped.
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Dr. H.T. Orr (Institute of Human Genetics, University of
Minnesota, MN), and Dr. T. Meier (Albert Einstein College
of Medicine, Bronx, NY 10461) kindly provided the plas-
mid pYY23-coilin. Full-length coilin was subcloned into the
pLex-BD, pB42-AD and pcDNA3.1/HisC plasmids. For
constructions of the pLexA-p80 coilin1 – 476 plasmids,
pGEX-5X-1-p80 coilin266–576, and pcDNA3.1/HisA-p80
coilin266–576, the BamHI-XhoI p80 coilin1–476 and p80
coilin266–576 cDNAs were amplified by polymerase chain
reaction (PCR). The in-frame insertions of all PCR products
and junctions of the constructs were confirmed by sequence
analysis with the ABI 310 Genetic Analyzer (Perkin-Elmer,
USA).
2.2. Yeast two-hybrid screening
The yeast two-hybrid screening procedure was described
previously [8]. A total of 2.5 106 independent transform-
ants were plated on a minimal medium containing X-gal (5-
bromo-4-chloro-3-indolyl-h-D-galactoside), but lacking ura-
cil, histidine, tryptophan and leucine. After incubation at
30 jC for 4 to 6 days, positive colonies were picked. The
inserts of selected positive clones were sequenced and
aligned in NCBI BLAST database.
2.3. Antibodies
For generating polyclonal antibodies against ataxin-1,
glutathione-S-transferase (GST)-fusion protein containing
the ataxin-1 C-terminus (leucine 539 to lysine 816) was
expressed in E. coli, purified through gel electrophoresis,
and used to immunize rats. Anti-A539, the resulting
immune serum, could detect both the wild-type and mutant
ataxin-1 in Western blots and immunofluorescence assays of
transfected cells. The anti-p80 coilin rabbit serum was
kindly provided by Dr. T. Meier. M2 anti-FLAG and
monoclonal anti-Xpress antibodies were respectively pur-
chased from Eastman Kodak and Santa Cruz.
2.4. In vitro transcription/translation
The in vitro translation reactions were carried out using
the TNT Quick Coupled Reticulocyte Lysate System (Prom-
ega). Bait cDNA (1.5 Ag) was used in the presence of the
TNT Rabbit Reticulocyte Lysate with [35S]-methionine per
manufacturer’s protocol.
2.5. GST pull down assay
The soluble proteins of E. coli cell lysates expressing
GST-p80 coilin were incubated with 100 Al of glutathione–
Sepharose beads for 1 h at 4 jC. After washing three times
with PBST, GST-p80 coilin proteins attached to the beads
were incubated with 15 Al of the In Vitro Transcription/
Translation (IVT) protein product in 500 Al of bindingbuffer containing 20 mM Tris–HCl (pH 7.5), and 50 mM
NaCl supplemented with protease inhibitors (2 mM phenyl-
methylsulfonyl fluoride (PMSF), 10 Ag/ml leupeptin, 10 Ag/
ml pepstatin and 1 Ag/ml aprotinin) for 2 h at 4 jC with
rotation. The beads were washed seven times in PBST and
resin-bound protein complexes were eluted from the beads
by boiling in 25-Al elution buffer containing 20 mM
glutathione, 50 mM Tris–HCl (pH 8.0) and 25 Al of sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer. The proteins were separated through
12% SDS-PAGE gel, transferred to nitrocellulose, dried and
exposed to X-ray film.
2.6. Co-precipitation and co-immunoprecipitation
Transfected COS7 cells were scraped, washed once with
PBS. The cells were pelleted by centrifugation, and lysed in
0.5% NP-40 lysis buffer (25 mM HEPES, 1 mM EDTA, 1
mM EGTA, 150 mM NaCl, 1 mM DTT and 0.5% NP-40)
supplemented with protease inhibitor mixture (2 mM PMSF,
10 Ag/ml leupeptin, 10 Ag/ml pepstatine, 1 Ag/ml aprotinin)
for 10 min at 4 jC. The cell extracts were centrifuged at
13000 rpm for 15 min at 4 jC and the supernatants were
harvested. For co-precipitation, glutathione–Sepharose
beads were added to total cell extracts and incubated for 2
h at 4 jC with end-over-end mixing. Beads were recovered
by centrifugation three times with 1 PBS supplemented
with 0.5% NP-40 and protease inhibitors. Resin-bound
protein complexes were eluted from the beads by boiling
in 25 Al of elution buffer containing 20 mM glutathione, 50
mM Tris–HCl (pH 8.0) and 25 Al of SDS-PAGE sample
buffer. The proteins were separated by 12% SDS-PAGE and
transferred onto polyvinylidene difluoride (PVDF) mem-
branes (Millipore). The membrane was blocked with 5%
nonfat milk and reacted with a 1:5000 dilution of the anti-
Xpress antibody (Invitrogen) for 2 h at room temperature.
Detections were performed by using the Enhanced Chem-
iluminescence (ECL) Western Blotting System (Amer-
sham). For each immunoprecipitation experiment, 250 to
300 Ag protein in 0.5-ml NP-40 lysis buffer was used, to
which a 1:200 dilution of the polyclonal anti-ataxin-1 anti-
body was added. After incubation overnight at 4 jC with
rotation, 30 Al of protein A–Sepharose (Sigma) was added,
and the reaction mixture was incubated for 2 h at 4 jC with
rotation. The beads were pulled down through centrifuga-
tion and washed three times with 1-ml NP-40 lysis buffer
containing protease inhibitors. Bound proteins were eluted
from the beads with 1 SDS-sample buffer, boiled for 5
min, and analyzed by Western blotting. Detections were
performed by using anti-Xpress (1:5000) antibodies.
2.7. Immunofluorescence and immunohistochemistry
Forty-eight hours after transfection, COS-7 cells were
prepared for immunofluorescence and confocal micro-
scopy. Cells were washed three times in PBS, fixed in
Fig. 1. Ataxin-1 interacts with p80 coilin. (A) Schematic representation of
the ataxin-1 proteins used and p80 coilin obtained through yeast two-hybrid
screening. The numbers indicate positions of amino acids in ataxin-1 and
p80 coilin. The black box represents the polyglutamine tract. (B) Interaction
between ataxin-1 and p80 coilin as determined by liquid h-galactosidase
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and quenched for 10 min in PBS containing 50 mM
NH4Cl. Subsequently, the cells were again rinsed three
times with PBS and permeabilized for 10 min in PBS
containing 0.1% Triton X-100. Coverslips with the cells
were then incubated in blocking buffer (2% bovine serum
albumin in PBS) for 1 h at 4 jC. The cells were incubated
again for 1 h at room temperature with the following
primary antibodies diluted in a block buffer: anti-p80
coilin (1:200), anti-Xpress (1:1000), M2 anti-FLAG
(1:1000) or anti-A539 (1:100). The coverslips were rinsed
three times with PBS and incubated for 1 h with goat anti-
rabbit fluorescein isothiocyanate (FITC) (Jackson Labora-
tories, West Grove, PA) and/or goat anti-mouse Texas-Red
(Jackson Laboratories), each at 1:800 in blocking buffer.
They were again rinsed three times with PBS and mounted
on glass slides by using FluoroGuard Antifade Reagent
(Bio-Rad Laboratories, Hercules, CA). Confocal images
were obtained from a Leica TCS-NT laser confocal micro-
scope (Heidelberg, Germany), and images were processed
at the Adobe Photoshop.
SCA1 transgenic mice (line B05) and wild-type non-
transgenic mice were generously provided by Dr. H.T. Orr.
Formalin-fixed paraffin sections of mouse brain were immu-
nohistochemically stained with antibodies to p80 coilin,
ubiquitin or ataxin-1. The procedures have been previously
described [12].
assays. Fragments of human ataxin-1 shown in the left panel were cloned
into the yeast expression vector pLexA-BD. h-Galactosidase activity was
quantified after yeast cells were co-transformed with the indicated construct
and pB42AD-p80 coilin464 – 576. As negative controls, pLexA-atrophin-1
(an unrelated protein gene), LexA-Lamin C, pLexA-BD alone and pB42AD
alone were used. As the positive control, pLexA-p53 and pB42AD-TAg
were used. Data were generated from three independent experiments.3. Results
3.1. Identification of p80 coilin as an ataxin-1-interacting
protein
To identify proteins that interact with wild-type ataxin-1,
we used the C-terminal portion of ataxin-1 as bait in yeast
two-hybrid screening (Fig. 1A). Yeast cells expressing
LexA-ataxin-1 were transformed with a human brain cDNA
library, and six positive clones were identified by screening
approximately 2.5 106 Trp+, Leu+ auxotrophic transform-
ants. One plasmid matched the sequence of coiled body-
specific p80 coilin. The others are ubiquitin-specific pro-
tease (USP7) [8], E2 ubiquitin conjugating enzyme (UbcH6)
(Hong et al. submitted for publication), and three unknown
clones. Sequence analyses revealed that the p80 coilin
cDNA fragment contained a 311-base pair (bp) C-terminal
region of the entire p80 coilin open reading frame (ORF),
which encodes a 576-amino-acid polypeptide with a molec-
ular mass of f 80 kDa (Fig. 1A). The reading frame was
further confirmed by expressing the cloned p80 coilin
cDNA in COS-7 mammalian cells.
To determine whether the activation of the reporter genes
lacZ and LEU2 reflects a specific interaction between p80
coilin and ataxin-1, we retransformed the pB42AD-p80
coilin464–576 (amino acids 464 576) plasmid into yeast
cells expressing either LexA-ataxin-1539–816 or LexA-BD,and selected the Trp+, Leu+ yeast transformants. Yeast cells
expressing LexA-ataxin-1539 –816 and pB42AD-p80 coi-
lin464–576 and grown on selective medium lacking Trp and
Leu showed high levels of h-galactosidase activity (Fig.
1B), whereas no h-galactosidase activity was detected in
cells containing pB42AD-p80 coilin464–576 and LexA-atar-
ophin-1917–1184 or LexA-BD, or pB42AD-p80 coilin464–576
and LexA-Lamin C, or LexA-BD and pB42AD, indicating
that a specific interaction exists between p80 coilin and
ataxin-1. Also, h-galactosidase activity was seen for the
positive control, LexA-p53 and pB42AD-TAg.
3.2. Binding region of ataxin-1 and p80 coilin
To determine the binding region for the interaction
between ataxin-1 and p80 coilin, we expressed deleted
versions of ataxin-1 and p80 coilin (Fig. 2A) as LexA-BD
and pB42AD fusion proteins, respectively, in yeast cells. The
LacZ reporter genes were activated in cells co-expressing
pB42AD-p80 coilin1–576 and LexA-ataxin-11–816 or LexA-
ataxin-1539–816 fusion proteins, and the pB42AD-p80 coi-
lin464–576 and LexA-ataxin-11–816 or LexA-ataxin-1539–816
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sidase activity was observed in cells expressing the protein
pairs LexA-ataxin-11–594 and pB42AD-p80 coilin1–576 or
LexA-ataxin-11–816 and pB42AD-p80 coilin1–476. Theseresults suggest that the C-terminal regions of ataxin-1 and
p80 coilin are essential for the observed protein–protein
interaction. In control experiments, co-expression of
pB42AD-p80 coilin464 – 576 and LexA-atrophin-1917 – 1184
Fig. 3. The length of the polyglutamine tract does not affect the strength of
the p80 coilin–ataxin-1 interaction. (A) COS-7 cells co-transfected with
p80 coilin and LacZ, wild-type (30Q)1 – 816 or mutant ataxin-1 (82Q)1 – 816.
The cell lysates were immunoprecipitated with anti-ataxin-1 antibodies. For
immunodetection, monoclonal anti-Xpress was used for detecting the
Xpress-tagged p80 coilin protein. Lanes 1 and 2 indicate that the p80 coilin
proteins co-immunoprecipitated with wild-type and mutant ataxin-1
proteins, respectively. Lane 3 indicates that wild-type ataxin-1 proteins
did not coimmunoprecipitate with the LacZ. As positive controls, the blot
was stripped and re-probed with the anti-ataxin-1 antibody to detect the
precipitated ataxin-1 protein (middle) and with the anti-Xpress antibody to
detect p80 coilin in cell extracts (bottom). (B) Plasmids encoding LexA
fusion proteins, which include a full-length wild-type ataxin-1 (30Q),
mutant ataxin-1 (82Q) or atrophin-1917 – 1184 (negative control), were
transformed into yeast cells expressing the pB42AD-p80 coilin or
pB42AD-p80 coilin266 – 576 proteins. The transformants were used for
liquid h-galactosidase assays.
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activity.
We confirmed the in vivo interaction detected through
the yeast two-hybrid assays by in vitro binding experiments.
Ataxin-1539–816 was in vitro translated (IVT) with [
35S]-
methionine, and glutathione-S-transferase (GST)-p80 coi-
lin266–576 was expressed as a recombinant protein in E. coli.
Ataxin-1539 – 816 proteins labeled with [
35S]-methionine
interacted with the GST-p80 coilin266–576 fusion protein
(Fig. 2C, lane 2), but not with GST alone (Fig. 2C, lane 3).
We assessed the in vivo interaction between ataxin-1539–816
and p80 coilin266 – 576 in mammalian cell lines by co-
precipitation experiments. Constructs containing pcDNA3/
GST-ataxin-1539 – 816 or pcDNA3/GST and pcDNA3.1/
HisC-p80 coilin266–576 were transfected into COS-7 cells.
The transfected cell extracts were mixed with glutathione–
Sepharose beads, and the proteins bound to the beads were
then probed with an anti-Xpress antibody to detect the
precipitated p80 coilin proteins. The p80 coilin266 – 576
protein was bound to the GST-ataxin-1539–816 fusion protein
(Fig. 2D, lane 2), but no significant interaction was
observed with the GST protein (Fig. 2D, lane 3). Interest-
ingly, we found a discrepancy of the level of interaction
between ataxin-1 and p80 coilin in (C) compared to (D),
which might result from the difference of additional com-
ponents present in the reticulocyte lysate and mammalian
cell lines. Taken together, these results show that ataxin-1
and p80 coilin interact both in vitro and in vivo and that
ataxin-1539–816 and p80 coilin476–576 are sufficient for their
interaction.
3.3. The interaction of p80 coilin and ataxin-1 is not
influenced by length of the polyglutamine tract
We further verified the interaction of p80 coilin and
ataxin-1 in mammalian cells by coimmunoprecipitation
assays. Constructs containing p80 coilin and either the
wild-type full-length ataxin-1 with 30 glutamines, or mutant
ataxin-1 with 82 glutamines were transfected into COS-7
cells. Forty eight hours post-transfection, total cell extracts
were prepared and immunoprecipitated with anti-ataxin-1
antibody. Fig. 3A shows that the wild-type ataxin-1 (30Q) or
mutant ataxin-1 (82Q) coimmunoprecipitated with p80
coilin (Fig. 3A, lanes 1 and 2) but not with pcDNA3.1/Fig. 2. Determining region of interaction between ataxin-1 and p80 coilin by liq
coilin. The numbers indicate positions of amino acids in ataxin-1 and p80 coilin.
hybrid systems, in combination with pB42AD-p80 coilin or pB42AD-p80 coilin de
p80 coilin266 – 597. The GST-fusion proteins, bacterially expressed and adsorbed to g
1. Lane 2 indicates that S35Metataxin-1539 – 816 proteins co-precipitated with GST
proteins did not co-precipitate with GST alone. Lane 1 indicates S35Metataxin
coilin266 – 576 and the pcDNA3-GST or pcDNA3-GST-fusion ataxin-1539 – 816
Sepharose beads. The bead-bound proteins were washed with PBST eluted from
with an anti-Xpress antibody to detect the precipitated p80 coilin266 – 576 proteins.
fusion ataxin-1539 – 816 proteins, and lane 3 indicates that p80 coilin266 – 576 prote
cotransfected cells as positive controls.HisB-LacZ proteins (lane 3), an indication that a strong
interaction exists in vivo between soluble ataxin-1 and p80
coilin.uid h-galactosidase assays. (A) Schematic representation ataxin-1 and p80
(B) LexA-ataxin-1 or LexA-ataxin-1 deletions were expressed in yeast two
letions. (C) In vitro binding between S35Metataxin-1539 – 816 and GST-fusion-
lutathione–Sepharose beads, were incubated with in vitro translated ataxin-
-fusion-p80 coilin266 – 597, and lane 3 indicates that
S35Metataxin-1539 – 816
-1539 – 816 as input. (D) COS-7 cells co-transfected with pcDNA3.1-p80
constructs. The transfected cell extracts were mixed with glutathione–
beads, separated by SDS-PAGE, transferred to Western blots and probed
Lane 2 indicates that p80 coilin266 – 576 proteins co-precipitated with GST-
ins did not co-precipitate with GST alone. Lanes 1 contains lysates from
Fig. 4. The distribution of p80 coilin is not influenced by mutant ataxin-1 in transgenic Purkinje cells. Purkinje cells of nontransgenic (A) and SCA1 transgenic
(B) mice were stained with anti-p80 coilin antibody. Most Purkinje cells show several dot-like coiled bodies in the nucleus and diffused p80 coilin proteins in
both the nucleus and cytoplasm. The small arrow-heads indicate coiled bodies. (C) Purkinje cells of nontransgenic mice were stained with anti-ubiquitin
antibody. Ubiquitin staining is diffusely localized in both the nucleus and cytoplasm. (D) Purkinje cells of SCA1 transgenic mouse were stained with anti-
ubiquitin antibody; ubiquitin-positive inclusions are detected in the nucleus. The large arrow-head indicates a ubiquitin-positive inclusion. (E) HeLa cells were
immunolabeled with anti-p80 coilin antibody coupled to Texas Red-conjugated antibody (red). (F) Polyclonal A539 anti-ataxin-1 coupled to FITC-conjugated
antibody (green). (G) Superimposition of both proteins under a fluorescent microscope is indicated in yellow (right). The white arrow-head indicates the
nucleolus.
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mutant ataxin-1 was quantified through liquid h-galactosi-
dase assays. The level of h-galactosidase activity in the
presence of wild-type ataxin-1 (30Q) was similar to the
activity observed in the presence of mutant ataxin-1 (82Q)
(Fig. 3B). In contrast, no interaction was observed between
p80 coilin464– 576 and atrophin-1917–1184 (DRPLA gene
product), the control protein. These results suggest that the
length of the polyglutamine tract does not affect the inter-
action between soluble ataxin-1 and p80 coilin proteins.
3.4. Coiled bodies are not redistributed by mutant ataxin-1
aggregates
We next examined by immunohistochemistry the distri-
bution of p80 coilin and ataxin-1 in the Purkinje cells of
nontransgenic mice or transgenic mice expressing a mutant
allele (B05 line containing 82Q) [13]. In B05 transgenicmice, a single large nuclear inclusion was observed in the
Purkinje cells (Fig. 4D, large arrow-head). All nuclear
inclusions were ubiquitin-positive (Fig. 4D) as well as
ataxin-1-positive (data not shown). The presence of a single
large nuclear inclusion is consistent with the previous result
that mutant ataxin-1 localizes throughout the nucleus and
forms a single large 2-Am nuclear inclusion [14]. Several
dot-like coiled bodies (Fig. 4B, small arrow-head) were
observed in both the nucleus and cytoplasm of Purkinje
cells, but the coiled bodies were not co-localized to the
nuclear inclusion as shown in Fig. 4D, indicating that
mutant ataxin-1 (82Q) does not influence the nuclear dis-
tribution of coiled bodies. In the Purkinje cells of non-
transgenic mice, no ataxin-1 nuclear inclusion was observed
(Fig. 4C), but several dot-like coiled bodies were distributed
in Purkinje cells (Fig. 4A). We could not confirm the
interaction between p80 coilin and ataxin-1 since there were
no ataxin-1 aggregates in the Purkinje cells of nontransgenic
Fig. 5. Ataxin-1 co-localizes with nucleoplasmic p80 coilin. HeLa cells were transfected with the indicated constructs and immunolabeled with polyclonal
A539 anti-ataxin-1 antibody coupled to FITC-conjugated antibody (green) and anti-Xpress antibody coupled to Texas Red-conjugated antibody (red), counter-
stained with DAPI. Superimposition of both proteins under a fluorescent microscope is indicated in yellow (right).
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coilin antisera in HeLa cells transfected with ataxin-1 (82Q),
no co-localization was found between coiled bodies and the
ataxin-1 (82Q) aggregates Fig. 4E–G).
3.5. p80 coilin co-localizes with ataxin-1 in the nucleoplasm
We next examined the cellular localization of p80 coilin
and ataxin-1 to further investigate their interaction in vivo.
Localization of the proteins was determined by immunofluor-
escence microscopy, which revealed that transfected p80
coilin proteins were distributed in the coiled bodies and
nucleoplasm, or sometimes nucleoli, of HeLa cells that had
not been transfected with ataxin-1 (data not shown). Trans-
fected ataxin-1 proteins and their aggregates were distributed
in the nucleoplasm, but not in coiled bodies and nucleoli as
shown in Fig. 4G. However, in HeLa cells transfected with
ataxin-1, transfected p80 coilin proteins colocalized with
aggregates of the ataxin-1 protein (Fig. 5), indicating that
ataxin-1 interacts and co-localizes with p80 coilin in the
nucleoplasm, but not in the coiled bodies and nucleoli.4. Discussion
In this study, we have identified a new ataxin-1-interact-
ing protein, coiled body-specific p80 coilin, whose function
remains to be determined. Although the highest concentra-
tion is present in coiled bodies, the p80 coilin protein is also
expressed throughout the nucleoplasm [15–17]. Especially
in the Xenopus germinal vesicle, as much as 85–90% of p80
coilin is in the soluble nucleoplasm, outside of the coiledbodies and nucleoli [18]. The nucleoplasm of eucaryotic
cells is highly compartmentalized despite the absence of
separating membranes. The conspicuous compartment is the
nucleolus, where ribosomal RNA is transcribed, processed
and assembled into pre-ribosomal particles together with
ribosomal proteins. Other nuclear domains include inter-
chromatin granule clusters, perichromatin fibrils and coiled
bodies [19–21]. Coiled bodies harbor mainly small nuclear
RNPs (snRNPs) that are involved in pre-mRNA splicing,
pre-ribosomal RNA processing and histone pre-mRNA 3V-
end formation [22].
Using in vitro and in vivo binding assays (Fig. 2) and
liquid h-galactosidase assays (Fig. 3), we showed that p80
coilin interacts with ataxin-1. These results suggest that this
interaction occurs inside the cells, although no colocaliza-
tion was found between coiled bodies and the ataxin-1
(82Q) aggregates, and it has been reported that ataxin-1 is
not ordinarily detected in coiled bodies or nucleoli by
immunofluorescence [14]. Clusters of p80 coilin have been
found around the nucleoli of HeLa cells treated with actino-
mycin D [23] and certain mutated forms of p80 coilin have
been detected in the nucleoli of transfected cells [24].
Recently it has been also reported that full-length p80 coilin
is essential for the recruitment of SMN, the spinal muscular
atrophy gene product, and the splicing of snRNPs to the
coiled bodies [25,26]. Our immunofluorescence assays
show co-localization of transfected attaxin-1 aggregates
and transfected p80 coilin proteins in the nucleoplasm
(Fig. 5), indicating that transfected ataxin-1 could alter the
localization of nucleoplasmic p80 coilin proteins but not the
organization of coiled bodies. However, in our experiments,
we did not observe a redistribution of endogeneous p80
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Purkinje cells of the SCA1 transgenic mice (Fig. 4B),
suggesting that endogenous p80 coilin protein might present
in a small portion of the nucleoplasm in HeLa and Purkinje
cells. In addition, Fig. 4 shows that mutant ataxin-1 co-
localizes with some of the coiled bodies but has no effect on
its normal nuclear distribution (Fig. 4E–G). We speculate
that this phenomenon is caused by accidental contact of the
nuclear structures formed by each protein.
Our liquid h-galactosidase assays (Fig. 3) reveal no
difference in the interaction strength between p80 coilin
and either the wild-type or mutant ataxin-1, implying that 82
glutamines in the mutant ataxin-1 do not affect the protein–
protein interactions of p80 coilin and ataxin-1 proteins in the
nucleus. Nonetheless, the elongated polyglutamine tract
could disrupt a cell-specific protein or process. From the
results of this study, although the p80 coilin protein shows
no changes in its distribution and expression level in the
Purkinje cells of SCA1 transgenic mice, close association
between p80 coilin and ataxin-1 might be involved in SCA1
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